STERIS’ (TSE:STE – Free Report) – Investment analysts at Cormark dropped their FY2025 EPS estimates for shares of STERIS’ in a report released on Monday, January 6th. Cormark analyst B. Watson now forecasts that the company will post earnings of $0.38 per share for the year, down from their prior estimate of $0.86. Cormark has a “Moderate Buy” rating on the stock.
Separately, Atb Cap Markets raised STERIS’ to a “strong-buy” rating in a report on Sunday, December 22nd.
STERIS’ Price Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Further Reading
- Five stocks we like better than STERIS’
- Short Selling: How to Short a Stock
- Why AMD Stock Might Already Be This Year’s Best Buy
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3 Promising Penny Stocks to Watch for Long-Term Gains in 2025
- What Does a Stock Split Mean?
- The 3 Kings of Buybacks in 2024: Can They Do It Again?
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
